Physiological relevance of apolipoprotein E recycling: studies in primary mouse hepatocytes
- PMID: 16154429
- DOI: 10.1016/j.metabol.2005.04.019
Physiological relevance of apolipoprotein E recycling: studies in primary mouse hepatocytes
Abstract
Studies in our laboratory have shown that a fraction of apolipoprotein (apo) E internalized by hepatocytes escapes degradation and is resecreted. Although the intracellular routing is not fully understood, our studies suggest that a portion of apoE recycles through the Golgi apparatus. Given the role of the Golgi apparatus in lipoprotein secretion and the fact that apoE modulates the hepatic secretion of very low-density lipoprotein, we hypothesized that recycling apoE has an effect on hepatic very low-density lipoprotein assembly and/or secretion. To test this hypothesis, apoE-/- mice were transplanted with bone marrow from wild-type mice. In this model, extrahepatic (macrophage-derived) apoE is internalized by the hepatocytes in vivo and is resecreted when the hepatocytes are placed in culture. Unexpectedly, our studies demonstrate that recycling apoE has little effect on hepatic lipid content or hepatocyte triglyceride secretion. In addition, recycling apoE has little effect on the expression of enzymes and proteins involved in lipid synthesis as well as plasma lipoprotein apoproteins. We conclude that the physiological relevance of apoE recycling may not be related to cell-specific functions, such as lipoprotein assembly in the liver. Rather, recycling may provide a mechanism for modulating general cellular effects such as intracellular cholesterol transport or cholesterol efflux.
Similar articles
-
Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.J Clin Invest. 1997 Dec 1;100(11):2915-22. doi: 10.1172/JCI119841. J Clin Invest. 1997. PMID: 9389759 Free PMC article.
-
The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice.J Hepatol. 2004 Apr;40(4):599-606. doi: 10.1016/j.jhep.2003.12.011. J Hepatol. 2004. PMID: 15030975
-
Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E284-90. doi: 10.1152/ajpendo.00601.2007. Epub 2007 Nov 20. Am J Physiol Endocrinol Metab. 2008. PMID: 18029445
-
Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis.Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):442-8. doi: 10.1161/01.ATV.0000201282.64751.47. Epub 2005 Dec 22. Arterioscler Thromb Vasc Biol. 2006. PMID: 16373604 Review.
-
The cell biology and physiologic relevance of ApoE recycling.Trends Cardiovasc Med. 2000 Jan;10(1):23-30. doi: 10.1016/s1050-1738(00)00033-5. Trends Cardiovasc Med. 2000. PMID: 11150725 Review.
Cited by
-
Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks.EMBO J. 2008 Apr 9;27(7):1017-28. doi: 10.1038/emboj.2008.51. Epub 2008 Mar 20. EMBO J. 2008. PMID: 18354499 Free PMC article.
-
The effect of old age on apolipoprotein E and its receptors in rat liver.Age (Dordr). 2010 Mar;32(1):69-77. doi: 10.1007/s11357-009-9115-2. Epub 2009 Oct 7. Age (Dordr). 2010. PMID: 19809892 Free PMC article.
-
Lipid profiling reveals arachidonate deficiency in RAW264.7 cells: Structural and functional implications.Biochemistry. 2006 Dec 12;45(49):14795-808. doi: 10.1021/bi061723j. Biochemistry. 2006. PMID: 17144673 Free PMC article.
-
Apolipoprotein e sets the stage: response to injury triggers neuropathology.Neuron. 2012 Dec 6;76(5):871-85. doi: 10.1016/j.neuron.2012.11.020. Neuron. 2012. PMID: 23217737 Free PMC article. Review.
-
Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.Cardiovasc Res. 2016 May 15;110(2):268-78. doi: 10.1093/cvr/cvw053. Epub 2016 Mar 15. Cardiovasc Res. 2016. PMID: 26980204 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous